跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Nevirapine Prolonged-release tablets
Approved
化学药品
Nevirapine Prolonged-release tablets
WEST WARD COLUMBUS INC
🇨🇳 National Medical Products Administration
Approval Date
Feb 24, 2017
Approval ID
7MazXcXg5b0
Company
WEST WARD COLUMBUS INC
Type
化学药品
Approval Details
Approval Id
7MazXcXg5b0
Approval Number
H20170072
Generic Name
奈韦拉平缓释片
Generic Name En
Nevirapine Prolonged-release tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
400mg
Reg Date
2017-02-24
Expired Date
2020-11-08
Company Name
WEST WARD COLUMBUS INC
Company Address
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany
Production Company Name
WEST WARD COLUMBUS INC
Production Company Address
1809 Wilson Road,Columbus,Ohio 43228,USA
Company Detail Path
/organization/west-ward-columbus-inc
Production Company Detail Path
/organization/west-ward-columbus-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 24, 2017
Approval ID
7MazXcXg5b0
Type
化学药品
Back to NMPA Approvals
奈韦拉平缓释片 - NMPA Drug Approval Details